Gasilus Pharmaceuticals Inc. is a pioneering vaccine company based in Hayward, CA, dedicated to revolutionizing vaccine development using Chimeric Gas Vesicles (CGVs) - a cutting-edge protein nanotechnology platform. Their innovative approach allows for targeted delivery of protein fragments to stimulate the immune system, offering potential solutions for a wide range of diseases including infectious diseases, cancers, autoimmune disorders, and neurodegenerative conditions.
Founded in 2020, Gasilus Pharmaceuticals is leading the way in vaccine innovation with a commitment to improving global health outcomes. Their focus on developing next-generation vaccines for both human and animal health showcases their dedication to shaping the future of healthcare through advanced technology and research.
Generated from the website